A new vaccine candidate for life-threatening respiratory viruses is being tested by researchers in Queensland.
The vaccine, developed by Vicebio aims to prevent serious respiratory viruses respiratory syncytial virus (RSV) and Human metapneumovirus (hMPV), which are particularly serious for very young and elderly people as well as placing considerable burden on hospital systems.
Produced By: Toni Pankaluic
Featured In Story: Professor Keith Chappell – Virologist from the University of Queensland
First aired on The Wire, Friday 22 November 2024